Physician profile
Aaron A Stein
NPI 1487644548
$1,398.37
in general payments reported to CMS, 2019-2025
16 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $293 · 2021: $241 · 2022: $144 · 2023: $110 · 2024: $167 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $436.30 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $298.04 | 2019-2025 | |
| Esperion Therapeutics, INC. | $150.00 | 2020 | |
| Abbott Laboratories | $147.96 | 2020-2023 | Cardiomems |
| Novo Nordisk INC | $113.37 | 2025 | Wegovy |
| Integra Lifesciences Corporation | $47.16 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Merck Sharp & Dohme LLC | $42.25 | 2022-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.56 | 2023 | Lifevest |
| Amgen INC. | $26.20 | 2019-2020 | |
| Irhythm Technologies, INC. | $25.13 | 2020-2022 | |
| Cvrx, INC. | $15.00 | 2024 | Barostim Neo System |
| Pfizer INC. | $15.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.93 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.58 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.80 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.